| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |